ARROW Exploration Corp. Announces Changes to the Board of Directors and Management
CALGARY, Alberta, Feb. 04, 2020 (GLOBE NEWSWIRE) — ARROW Exploration Corp. (“Arrow” or the “Company”) (TSXV: AXL) announced today that […]
Constellium awarded ‘Best Performer’ by Airbus
PARIS, Feb. 04, 2020 (GLOBE NEWSWIRE) — Constellium SE (NYSE: CSTM) was recognized with the “Best Performer Award” by Airbus […]
Vishay Reports Results For Fourth Quarter and Year 2019
Revenues for Q4 2019 of $610 million and for the year 2019 $2,668 millionGross Margin Q4 of 22.2% and year […]
Hamilton Lane Incorporated Reports Third Quarter Fiscal 2020 Results, With Year-To-Date Management & Advisory Fees Growing by 12% and Assets Under Management Growing by 13% Year-Over-Year
BALA CYNWYD, Pa., Feb. 04, 2020 (GLOBE NEWSWIRE) — Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ: HLNE) […]
Cerence to Announce Fiscal First Quarter Results on February 11, 2020
BURLINGTON, Mass., Feb. 04, 2020 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, will announce […]
CareDx Launches AiTraC Conference
SOUTH SAN FRANCISCO, Calif., Feb. 04, 2020 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused […]
Tonix Pharmaceuticals to Participate in Upcoming February Investor Conferences
NEW YORK, Feb. 04, 2020 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) announced today […]
Digital Ally Awarded Largest Body Camera/Video Solution Contract in Its History
Three-Year Sole-Source Supply Contract For Up To 5,000 Body Cameras and Software Infrastructure/Back Office Awarded to Digital By a National […]
Summit Therapeutics to Present at the 2020 BIO CEO & Investor Conference
Summit Therapeutics plc (‘Summit’ or the ‘Company’)Summit Therapeutics to Present at the 2020 BIO CEO & Investor ConferenceOxford, UK, and Cambridge, […]
Altimmune to Present at Upcoming Investor and Scientific Conferences
GAITHERSBURG, Md., Feb. 04, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that management […]
